EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ Dainippon Sumitomo Pharma
@ Noevir Holdings
@ T&K TOKA
@ KUMIAI CHEMICAL INDUSTRY
@ NIPPON KAYAKU
@ 小林製薬
@ Toray Industries
@ Nichi-Iko Pharmaceutical
@ TOWA PHARMACEUTICAL
@ KANEKA
@ TOAGOSEI CO
@ SAWAI PHARMACEUTICAL
@ 長谷川香料
@ 栄研化学
@ MANDOM
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
PIONEER etc.
graph
KIKUSUI ELECTRONICS etc.
graph
KIKUSUI ELECTRONICS etc.
graph
PIONEER
graph
Yushiro Chemical Indutry
graph

Credit Rating Analysis: Dainippon Sumitomo Pharma (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): Dainippon Sumitomo Pharma (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  A  Credit is high, but affected by biz environs. ¥ 347 B
-0.76%
¥ 24 B
29.84%
¥ 10 B
16.38%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating AAABBB
Total Assets
¥ 573 B
¥ 607 B
¥ 634 B
¥ 634 B
Net Assets
¥ 327 B
¥ 349 B
¥ 374 B
¥ 377 B

Financial Statement Risk Analysis: Dainippon Sumitomo Pharma (Annual ) (Consolidated )

[Date: 2013-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 347 B) is first term Sales (¥ 350 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -55 B) & Financial Cash Flow (¥ -20 B) is a minus, Operating Cash Flow (¥ 49 B) is a plus,
Dividend
Under the situation of Net Income (¥ 10 B) & Operating Cash Flow (¥ 49 B) , Dividend (¥ -7 B) is paid.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 350 B) is first term Sales (¥ 379 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ 8 B) is first term Net Income (¥ 16 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (2.46%) is first term Net Profit Margin (4.43%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -4 B) & Financial Cash Flow (¥ -32 B) is a minus, Operating Cash Flow (¥ 48 B) is a plus,
Dividend
Under the situation of Net Income (¥ 8 B) & Operating Cash Flow (¥ 48 B) , Dividend (¥ -7 B) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 3 B) is Sales first term ratio (¥ -29 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is decrease )
Net Income (¥ 16 B) is first term Net Income (¥ 20 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (4.43%) is first term Net Profit Margin (7.07%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -6 B) & Financial Cash Flow (¥ -20 B) is a minus, Operating Cash Flow (¥ 55 B) is a plus,
Dividend
Under the situation of Net Income (¥ 16 B) & Operating Cash Flow (¥ 55 B) , Dividend (¥ -7 B) is paid.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (7.07%) is first term Net Profit Margin (7.57%) less , there is a possibility that the profitability has deteriorated.
Dividend
Under the situation of Net Income (¥ 20 B) & Operating Cash Flow (¥ 26 B) , Dividend (¥ -7 B) is paid.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -21 B) & Financial Cash Flow (¥ -11 B) is a minus, Operating Cash Flow (¥ 26 B) is a plus,
Dividend
Under the situation of Net Income (¥ 19 B) & Operating Cash Flow (¥ 26 B) , Dividend (¥ -7 B) is paid.

Related Information: Dainippon Sumitomo Pharma (Annual )

Statement Type
Annual : Dainippon Sumitomo Pharma
First quarter : Dainippon Sumitomo Pharma
Second quarter : Dainippon Sumitomo Pharma
Third quarter : Dainippon Sumitomo Pharma
Analysis Menu
@Outline : Dainippon Sumitomo Pharma
@Statement : Dainippon Sumitomo Pharma
@Rating : Dainippon Sumitomo Pharma
@Indicator : Dainippon Sumitomo Pharma
@Download : Dainippon Sumitomo Pharma
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Osaka - EDIUNET Prefectures
Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ Dainippon Sumitomo Pharma 4506 TSE 1st Chemicals 3 Annual A

Related Company

@ 東京応化工業 (Sales ¥ 72 B)
@ Toray Industries (Sales ¥ 1.5 T)
@ Nichi-Iko Pharmaceutical (Sales ¥ 93 B)
@ TOWA PHARMACEUTICAL (Sales ¥ 55 B)
@ MANDOM (Sales ¥ 60 B)
@ NIPPON KAYAKU (Sales ¥ 128 B)
@ 小林製薬 (Sales ¥ 121 B)
@ 長谷川香料 (Sales ¥ 45 B)
@ ONO PHARMACEUTICAL (Sales ¥ 145 B)
@ Hitachi Chemical (Sales ¥ 464 B)
@ Noevir Holdings (Sales ¥ 46 B)
@ Dr.Ci:Labo (Sales ¥ 33 B)
@ KANEKA (Sales ¥ 476 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.091 sec.)